Report: White House plans to slash funding for fed Drug Control Policy office

Report: White House plans to slash funding for fed Drug Control Policy office

On Friday, Politico’s Dan Diamond reported that the White House will gut funding for the Office of National Drug Control Policy, the executive branch agency coordinating efforts to fight the opioid epidemic that has swept through rural areas of America over the last few years.

And if you navigate to the Office of National Drug Control Policy website, it’s … not much of a website. The homepage reads: “Check back soon for more information.”

Diamond reports that Trump’s proposed 2018 budget would slash funding for the office by 95 percent, drastically cutting staff and completely eliminating a program that helps communities fight addiction at the local level.

What does that mean for the future of addiction treatment?

There are a few ways the government attempts to fight drug use in the U.S. The most visible way is with law enforcement: Stopping drugs at the border, and arresting and prosecuting dealers and users. But the other side of the addiction fight is a public health approach that focuses on access to treatment facilities, education and support for recovering addicts, and facilities like needle exchanges that lower the transmission of blood-borne diseases.

Those two schools of thought can sometimes be at odds; while some administrations have prioritized law enforcement (think “the war on drugs,” with mandatory sentencing requirements, expanded policing and “three-strikes” laws), others, including the Obama administration, focused on the public health approach.

As a presidential candidate, and again after the election, Trump promised to fight the opioid crisis with a two-pronged strategy: A border wall to stop the flow of drugs into the country, among other things, and localized efforts to fight addiction with clinics and increased access to care. Those promises suggested Trump was interested in at least maintaining the public health programs currently in place.

Does gutting the Office of National Drug Control Policy do that?

Trump did announce the formation of a new drug commission, led by New Jersey Gov. Chris Christie, R, in March. But it’s hard to imagine the new commission would get the kind of funding that went to the Office of National Drug Control Policy.

Trump says he will “fight to increase access to life-saving treatment,” and that “we have to work with people to get off it.” Trump’s budget is a long way from being approved – remember, Congress holds the power of the purse, and it seems unlikely that Congress would cut funding for anti-drug programs so drastically. But it could be a broader signal that the Trump administration is moving away from treatment programs, and toward more of a law enforcement approach.

(Why?)

Published at Fri, 05 May 2017 20:35:55 +0000

RocVape Vaporizer Reviews

RocVape Vaporizer Reviews

Tuesday, May 2nd, 2017

Vaporizer Reviews

RocVape sent us a couple of vaporizers to review. Following is a review of these two vaporizers by our expert reviewer KC:

  • Origo CVB – Utilizing the latest Complete Vaping Box technology, the Origo CVB presents an incredibly small form factor and looks extremely stealthy. It designed with great ease of use. Give the leak-proof built-in tank, you are ready to go!
  • Origo CVT – The new Complete Vaping Tube technology makes the Origo CVT a next generation vaping starter kit! It integrates the battery, chip set and tank, etc. into a whole, presenting incredible simplicity and solidity. Pull it out of your purse or pocket, give the leak-proof tank a refill and enjoy the delicious clouds!

RocVape Vaporizer Review Photos

Origo CVT Vaporizer Review

PROS:

  • Small and easy to conceal
  • Top fill to prevent leaking
  • Good throat hit
  • Adjustable air flow
  • Good battery life
  • Leak-proof tip to prevent juice in your mouth
  • Cool/sleek design
  • Good beginner or on-the-go vape
  • Changeable tip
  • Cheap price (around $25)

CONS

  • Tank is smaller than it looks / does not hold much juice
  • No adjustable heat
  • Does not work when charging!
  • Vape is nicotine only, no THC

OVERALL

The Origo CVT is a good vape for vapers who are not looking for the “cloudy” type vapes. this vape is very easy to use, comes with all the necessary equipment, and is a good mod. One definite improvement they can make to this vape is to allow it to hit while charging.

Origo CVB Vaporizer Review

PROS

  • Very small and easy to conceal
  • Light weight
  • Cool design
  • Built-in tank helps prevent leaking
  • Air flow on the top to help prevent leaking
  • Good/strong hit
  • Button on top which helps prevent “firing” when in your pocket
  • Interchangeable tips
  • Good battery life
  • Standard micro USB charger
  • Comes with all necessary items
  • Good price (around $43)

CONS

  • Small tank
  • Cannot change wattage
  • Cannot hit while charging!
  • Vape is nicotine only, no THC

OVERALL

Overall, I would give this vape a 5/5. Some vapers like huge clouds. I personally like when a vape has a good “throat hit.” the Origo CVB has the ability to blow big clouds or just keep it simple and have a small hit. With its adjustable air flow, this vape meets the needs of all vapers. I would recommend this product to anyone in the vaping industry who is looking to have a simple mod, but still get the satisfaction of a well-designed vape.

(Why?)

Published at Tue, 02 May 2017 04:19:24 +0000

Medical Cannabis for PTSD Bill Passed by New York Assembly

Medical Cannabis for PTSD Bill Passed by New York Assembly

Legislation to expand New York’s medical cannabis program has been given approval by New York’s Assembly.

Assembly Bill 7006, sponsored by a bipartisan coalition of 36 Assemblymembers (30 Democrats and 6 Republicans), has received approval from the full Assembly. It will now be sent to the Senate, where passage would send it to Governor Andrew Cuomo for consideration.

The proposed law would add post traumatic stress disorder (PTSD) to New York’s list of qualifying medical cannabis conditions. This would allow those with the condition to legally purchase, possess and use cannabis and cannabis products, given they receive a recommendation from a physician and register with the state.

If Assembly Bill 7006 becomes law, New York would join Minnesota, New Jersey, Michigan, California, Illinois, Connecticut, Delaware, Maine, Massachusetts, New Mexico, Arizona, Washington, Rhode Island and Oregon as states that allow those with PTSD to legally use medical cannabis.

About Anthony Martinelli

Anthony, co-founder and Editor-in-Chief of TheJointBlog, has worked closely with numerous elected officials who support cannabis law reform, including as the former Campaign Manager for Washington State Representative Dave Upthegrove. He has also been published by multiple media outlets, including the Seattle Times. He can be reached at TheJointBlog@TheJointBlog.com.

(Why?)

Published at Wed, 03 May 2017 16:09:13 +0000

Vermont Legislature Approves Medical Marijuana Expansion Bill

Vermont Legislature Approves Medical Marijuana Expansion Bill

A bill to expand Vermont’s medical marijuana program, including doubling the number of dispensaries and expanding the list of qualifying conditions, has been passed by Vermont’s Legislature.

Senate Bill 16 was passed by the House of Representatives today with an 130 to 16 vote; the proposal has already been passed by the Senate, meaning it will soon be sent to Governor Phil Scott for consideration.

The proposed law would double the number of medical cannabis dispensaries in the state from four to eight. It would also increase the amount of cannabis a patient can possess to three ounces, allow patients to grow cannabis at home even when they have a designated dispensary, and would expand the list of qualifying medical cannabis conditions to include post traumatic stress disorder (PTSD), Crohn’s disease and Parkinson’s disease.

In addition, the bill would allow dispensaries to advertise, increase the amount of cannabis patients can possess to three ounces, waves the three-month patient-health care professional relationship requirement “when the patient is referred to a specialist who completes a full examination and signs the medical verification form”, allows patients and caregivers to cultivate cannabis at home even if they have a designated dispensary, allows dispensaries to become for-profit, and requires the Agency of Agriculture, Food and Markets to “independently test marijuana-infused edible or potable products sold by a dispensary to ensure the appropriate labeling of the tetraydrocannabinol content.”

About Anthony Martinelli

Anthony, co-founder and Editor-in-Chief of TheJointBlog, has worked closely with numerous elected officials who support cannabis law reform, including as the former Campaign Manager for Washington State Representative Dave Upthegrove. He has also been published by multiple media outlets, including the Seattle Times. He can be reached at TheJointBlog@TheJointBlog.com.

(Why?)

Published at Tue, 02 May 2017 20:08:59 +0000

Illinois Cannabis Update

Illinois Cannabis Update

Illinois Cannabis Update

Action has been heating up in Illinois recently regarding cannabis regulation that culminated in legislative hearings this week centered on the prospect of potential legalization of recreational cannabis use in the state. On Wednesday, a joint House and Senate Appropriations Committee met to take testimony from Barbara Brohl who is the Executive Director of the Colorado Department of Revenue. The hearing was in response to recent legislative initiatives that have been introduced in both chambers of the Illinois General Assembly to authorize the regulation and taxation of cannabis for recreational use. Brohl provided information and took questions from committee members regarding Colorado’s experience with recreational use sales. Among the highlights of her testimony were specifics regarding the Colorado regulatory and tax structure for recreational use cannabis as well as what she perceived as her state’s successes and struggles with implementation of this process. Significant debate was had between Brohl and committee legislators regarding the state’s tax structure and the resulting revenues generated for various Colorado state services. This discussion played out against the backdrop of Illinois’ ongoing state budget crisis and lawmaker’s continued efforts to find additional revenue streams. Another focus of the debate centered on the ongoing cannabis banking conundrum that has caused significant difficulty for cannabis businesses and their customers from utilizing traditional banking services across the country. Further committee debate focused on legislator’s concerns with reports of increased emergency room visits in Colorado and other recreational use states as well as concerns with DUI enforcement and restrictions on access to minors. Rounding out the testimony provided to the committee this week was a representative of the National Conference of State Legislatures (NCSL) who gave a national update on which states have authorized recreational use of cannabis and their preliminary findings. One particularly interesting note from this testimony was that all states that now allow recreational use have done so via ballot initiative and not through direct legislative authorization. Most Illinois cannabis observers agree that direct legislative authorization will be necessary here due to the state’s notoriously difficult ballot initiative process. 

While sponsors of the pending Illinois legislation aimed at authorizing recreational cannabis use have conceded passage of legislation is unlikely this spring, they announced to the committee  this week that more in-depth hearings are to follow in the coming weeks and months with an ultimate goal of calling legislation for a vote at a later date.   

A link to both the language of the pending bills mentioned above are linked below. They are identical and pending in both the Illinois House and Senate at this time.

HB 2353

http://www.ilga.gov/legislation/100/HB/10000HB2353ham001.htm

SB 316

http://www.ilga.gov/legislation/100/SB/10000SB0316sam001.htm

(Why?)

Published at Thu, 20 Apr 2017 16:00:00 +0000

Iowa takes small step to expand medical marijuana program, but advocates want more

Iowa takes small step to expand medical marijuana program, but advocates want more

DES MOINES, Iowa — A medical marijuana oil program approved by the Iowa Legislature might not offer much help to patients with qualifying medical conditions, but advocates say it’s at least a step in the right direction.

The measure approved by lawmakers in the final hours of the legislative session Saturday would expand a little-used program now only available to people with epilepsy. If signed by Gov. Terry Branstad, the law would allow the limited production of cannabis oil at two locations in Iowa and legalize its use for an additional eight conditions.

Despite the expansion, medical marijuana advocates said the decision to cap the level of the active ingredient and limit the means of ingestion means the program has limited value.

Sen. Joe Bolkcom, a Democrat from Iowa City, called the program “the worst in the country.”

“For people who were opposed to doing anything, I suppose they think this is a big deal,” he said. “But the fact of the matter is that they shouldn’t have put all the conditions in the bill because the medicine isn’t going to provide a therapeutic benefit for eight of the nine conditions, and that’s sad.”

Besides prohibiting smoking, vaporizing or consuming marijuana edibles, the bill limits the amount of tetrahydrocannabinol, or THC, allowed in the oil to 3 percent. THC is the compound known for psychoactive effects, and by capping it at 3 percent advocates said it limits the oil’s potential to help conditions besides seizures.

Some programs, mainly in conservative states, have caps with even smaller percentages of THC.

Only 38 people have medical cannabis cards under Iowa’s current system, which makes it illegal to manufacture or distribute the oil. It’s unclear how many more would enroll if the new program is signed into law.

Sunil Kumar Aggarwal, a doctor researching cannabinoid medicine at the University of Washington School of Medicine, said some conditions besides seizures could benefit from low-THC oil, but that the benefit is less certain because of the cap.

“It’s an extremely non-scientific regulatory framework for cannabis,” he said. “It’s all politics. This is no way to do medicine.”

Rep. Jarad Klein, a key supporter of the legislation, said the program’s limitations stem from the hesitation of House Republicans to legalize any form of marijuana.

“A lot of my caucus said ‘We don’t feel comfortable with this issue at all,’” Klein said.

The bill would also create an advisory board to recommend changes to the cannabis oil program, though Iowa lawmakers would have the final say.

Klein acknowledged an interest in potentially raising the THC level above 3 percent if the medical board recommends it.

“A lot of this boils down to a compromise, and this is not necessarily … my personal ideal,” he said. “I had to get something I knew we could pass and that I have a high confidence the Governor will sign.”

The conditions covered in the expanded program include: cancer; multiple sclerosis; seizures; HIV or AIDS; Crohn’s disease; Amyotrophic lateral sclerosis; Parkinson’s disease; untreatable pain; and any terminal illness with a life expectancy of under a year.

The Marijuana Policy Project, a national lobbying organization, said 29 states have comprehensive medical marijuana programs, while 16 offer cannabidiol extract with minimal THC. By the group’s standards, Iowa falls in the second category and is not considered to have a “workable” medical marijuana program.

“It will certainly be beneficial to those suffering from seizure disorders, no question,” said Maggie Ellinger-Locke, legislative counsel for the organization. “But the THC cap will leave most patients behind.”

Nonetheless, Iowa Epilepsy Foundation director Roxanne Cogil praised the overall effort.

“We feel this is a significant step forward to ensure meaningful access for Iowans,” she said. “We do look forward to continue to working with legislators to help improve the program.”

(Why?)

Published at Fri, 28 Apr 2017 22:24:40 +0000

Mexico Lawmakers Approve Bill to Legalize Medical Marijuana

Mexico Lawmakers Approve Bill to Legalize Medical Marijuana

Mexico’s lawmakers have overwhelmingly passed a bill to legalize the medical use of marijuana.

According to Reuters, the bill sailed through the Senate in December, passed the Lower House of Congress on Friday, and will now be sent to President Enrique Pena Nieto, who is expected to sign it.

“The ruling eliminates the prohibition and criminalization of acts related to the medicinal use of marijuana and its scientific research, and those relating to the production and distribution of the plant for these purposes,” the Lower House said in a statement on its website.

The measure passed in a general floor vote with 371 in favor, seven against and 11 abstentions, and now classifies the psychoactive ingredient in marijuana, tetrahydrocannabinol (THC) as “therapeutic.”

Speaking in April 2016 at a special session where world leaders gathered to rethink global strategy in the war on drugs for the first time in two decades, Pena Nieto said drug use should be addressed as a “public health problem” and users should not be criminalized.

Pena Nieto, once a vocal opponent of drug legalization, has said the United States and Mexico should not pursue diverging policies on marijuana legislation. Last year, he proposed a bill to allow Mexicans to carry up to an ounce of marijuana, a measure that has since stalled in Congress.

About Anthony Martinelli

Anthony, co-founder and Editor-in-Chief of TheJointBlog, has worked closely with numerous elected officials who support cannabis law reform, including as the former Campaign Manager for Washington State Representative Dave Upthegrove. He has also been published by multiple media outlets, including the Seattle Times. He can be reached at TheJointBlog@TheJointBlog.com.

(Why?)

Published at Sat, 29 Apr 2017 14:45:17 +0000

Strain Review: Golden Pineapple From Phat Panda

Strain Review: Golden Pineapple From Phat Panda

Mrs. Nice Guy

Becks and the no good, very bad day.

At work we had to upgrade to a new version of Quickbooks and while the actual installation was a breeze, the program decided to fight with our check printing software. I spent about 4-5 hours updating and patching and about half way through this whole fiasco I actually had to stop and ask Google “Is Mercury in retrograde?”…YES. How could I forget…ugh. The problems were all resolved, but my day was ruined. The night before I predicted a breezy Thursday, silly me.

I left work in a sour mood and realized that with all the craziness I forgot to get gas, SERIOUSLY? Our weather is in this bipolar place right now where it can’t decide what it wants to be. Sun, rain, bright, dark, warm, cold, rinse, repeat. It’s fucking with my psyche and I was in desperate need for this mood to go far away.

After a much needed nap I decided to light up my 1 gram Golden Pineapple pre-roll from Phat Panda, purchased at the Herbery in Vancouver, Wa. Golden Pineapple is a sativa dominant hybrid bred from Golden Goat and Pineapple Kush. It has a fruity, tropical smell mixed with hints of a spicy pineapple. As far as the pre-roll is concerned it was nice and packed, I loosened it up by rolling it through my fingers, I find that helps it from running.

Close to about halfway through the thick fatty I started to feel relaxed. My body was tense and as every second passed I could feel it loosen up. My eyes lowered like venetian blinds, my head  felt like a balloon sailing through the sky and my shoulders started to feel like a weight had been lifted.

I expected to be SUPER high after smoking the whole joint, but I found the medium strength to be a pleasant experience. The mental and physical energy was at a medium, concentrated pace as well. It got me moving around a bit which was nice because I felt like an immovable boulder before. I was at ease, but motivated with a smooth demeanor. I went from feeling like a mix of Oscar the Grouch and Eeyore, to a radiating Beyonce at the 2017 Grammys.

Golden Pineapple is a nice strain to battle stress, anxiety, and depression. There’s a good amount of mental and physical energy with a focused tranquility way about it. It brought a sweet golden sunshine to a dark and blustery place.

Golden Pineapple: 5 – Rihanna

The post Strain Review: Golden Pineapple From Phat Panda appeared first on Mrs. Nice Guy.

(Why?)

Published at Fri, 28 Apr 2017 02:57:22 +0000

International org takes on creating safety and other standards for cannabis industry

International org takes on creating safety and other standards for cannabis industry

ASTM International, a century-old standards organization, gave the official go-ahead to establish a standards-writing committee for the cannabis industry, officials announced Tuesday.

ASTM’s board of directors approved the formation of Committee D37, a group that will develop standards for cannabis, its products and processes, officials said. The committee, reported on by The Cannabist in March, is scheduled to hold its first meeting on June 11.

“This committee will help meet a need for safety and standardization in this fast-growing industry,” Dr. Ralph Paroli, D37 chairman and director of R&D in measurement science and standards at the National Research Council of Canada, said in a statement. “With decades of experience working with industries such as agriculture, packaging, pesticides, and pharmaceuticals, ASTM International and its members are uniquely qualified to develop standards for the cannabis industry.”

The new cannabis committee plans to develop standards in the following technical areas:

• Indoor and outdoor horticulture and agriculture
• Quality management systems
• Laboratory
• Processing and handling
• Security and transportation
• Personnel training, assessment and credentialing

(Why?)

Published at Tue, 25 Apr 2017 22:33:10 +0000

10 Surprising Celebrity Marijuana Investors

10 Surprising Celebrity Marijuana Investors

By Dianna Benjamin, WikiLeaf.com

Investors in cannabis understand the danger for the dollar.  Though 28 states and Washington D.C. have legalized cannabis, the plant’s future is ambiguous.  Cannabis is federally illegal, which means that at any time and regardless of state law, the feds could legitimately shut the entire operation down.

While risky, the burgeoning cannabis industry has been abundantly profitable.  Here’s the 2016 revenue breakdown to prove it:

  • In 2016, the legal cannabis industry was responsible for producing $6.9 billion. That number is predicted to increase to $21.6 billion by 2021.
  • Based on 2016 results, the state of Washington is predicted to make about $270 million annually.
  • Oregon expects to generate $60 million in tax revenue each year.
  • Alaska is predicted to make $19.2 million in pot taxes a year.
  • If cannabis is rescheduled and legalized by the federal government, the industry could generate $28 billion in tax revenue each year.

The federal law’s position on marijuana is grounded in bigoted societal views, and ignorance and prejudice are tough adversaries to face. The people who choose to use their money and reputations to invest in cannabis are among those who are bringing legitimacy to the movement.

Read on for a list of 10 investors taking on the challenge and pioneering the future of the cannabis industry.

Dick Wolf—Creator of Law and Order

In the criminal justice system, marijuana remains federally illegal although several states have legalized its medical and/or recreational use.  A special team of rich people has decided to invest in this emerging market.  These are their stories.

In April 2014, Dick Wolf, the legendary crime show producer of the Law and Order franchise, invested $1.5 million in DigiPath, an independent marijuana-testing lab.

Nick Lachey—98 Degrees Singer, Actor

Had theNick Lachey cannabis investor, investors in cannabis November 2015 ballot initiative Issue 3 been passed in Ohio, Nick Lachey, co-owner of a 29-acre farm, would have ruled Ohio’s marijuana industry with a handful of other elite investors controlling the ten ballot-sanctioned growth farms.  The ballot failed, but Lachey remains hopeful, tweeting, “Change takes time” in response to the loss.

Oscar Robertson—Former NBA Star

Oscar “The Big O” Robertson is known for being one of the greatest all around athletes in professional basketball history.  But he is also an advocate for medical marijuana and invested in the campaign supporting Ohio’s marijuana legalization 2015 ballot initiative, Issue 3.  When explaining his motive to invest, Robertson stated, “It’s a terrifying feeling when you can’t help someone suffering from cancer or another debilitating medical condition—I know from personal experience.  But medical marijuana can give our loved ones relief.” The Ohio ballot initiative was voted down, maintaining Ohio’s status as a prohibition state.

Frostee Rucker –NFL Player

Disrupting the offense’s quarterback isn’t the only thing Frostee Rucker, defensive end for the Arizona Cardinals, is committed to doing.  Rucker’s support of Ohio’s Issue 3, the November 2015 ballot initiative attempting to legalize medical and recreational marijuana, certainly disrupted the stigma associated with cannabis consumption.  In fact, Rucker was able to convince Bill Foster, owner of the multimillion-dollar logistics company A1QLS to help fund the campaign by exposing him to cannabis’ powerful therapeutic benefits.

Roseanne Barr—Comedian/Actress

Roseanne Barr cannabis investor In February 2016, Roseanna Barr, pot advocate, comedian, and a former presidential candidate planned to open a dispensary in Santa Ana, CA called Roseanne’s Joint.  Barr is a medical marijuana user herself, harnessing cannabis’ therapeutic qualities to treat her glaucoma and macular degeneration.  For mysterious reasons, the dispensary never opened. Barr’s only comment was that “it didn’t work out for [her] and the investor.”

Cliff Robinson—Former NBA Player

This former Portland Trail Blazers star didn’t stop with basketball.  Robinson is blazing trails in the cannabis industry as well.  He recently opened a grow operation in Portland Oregon.  Robinson is motivated to; “distill the stigma around cannabis, the misperception that athletes and cannabis are incompatible.”  Robinson has also said, “Cannabis is definitely a more positive alternative to pharmaceuticals at the end of the day.  Those are synthetics.  I’m talking about something that’s natural that can bring the outcomes you’re looking for, be it for muscle tension or relaxation or preparedness.  There are a whole lot of different things that are beneficial.”

Melissa Etheridge—Singer

In 2004, Melissa Etheridge was diagnosed with breast cancer.  Today, she is cancer free, and she attributes her recovery to her daily, therapeutic use of cannabis.  That’s not surprising given the health benefits of cannabidiol, one of the most therapeutically significant cannabinoids present in the marijuana plant.  One of its benefits is the ability to suppress aggressive tumor growth.  Etheridge’s company, Etheridge farms, produces a variety of medical cannabis goods including wine tincture, edibles, topicals, and, of course, flower.

Founders Fund

 In early 2015, the investment company Founders Fund invested millions of dollars in the Seattle based private equity firm, Privateer Holdings.  Founders Fund is known for taking on projects in the fields of science, technology, and engineering.  The venture capital fund has invested in companies like Facebook, Spotify, and Airbnb.  Privateer Holdings, Founders Fund’s entrance into the marijuana industry, exclusively invests in legal cannabis, and the contribution backed in part by PayPal’s co-founder, Peter Thiel, will help the private equity firm continue to build mainstream cannabis companies and legitimize the market.

Whoopi Goldberg—Actress, Talk Show Host

Whoopi Goldberg cannabis investor, investors Whoopi Goldberg has plunged into California’s medical marijuana industry by investing her money and name into the medical cannabis line known as Whoopi & Maya Synergy. The line focuses on women’s health.  Specifically, Whoopi and Maya have created cannabis products meant to relieve menstrual discomfort.

Woody Harrelson—Actor

Woody Harrelson, actor best known for his role as Haymitch Abernathy in The Hunger Games, was one of over sixty people to apply to open a dispensary in Hawaii.  Unfortunately, in April 2016, the panel responsible for approving the licenses rejected Harrelson’s company, Single Organic Living.   Harrelson has long been a proponent of legalization, saying in 2002, “I think that it’s absurd that you throw people in jail for smoking a joint when alcohol is more destructive.”

About Anthony Martinelli

Anthony, co-founder and Editor-in-Chief of TheJointBlog, has worked closely with numerous elected officials who support cannabis law reform, including as the former Campaign Manager for Washington State Representative Dave Upthegrove. He has also been published by multiple media outlets, including the Seattle Times. He can be reached at TheJointBlog@TheJointBlog.com.

(Why?)

Published at Mon, 24 Apr 2017 17:14:25 +0000

Copyright http://cannabissales.net 2016. All rights reserved |